Loading...
•
Jun 30, 2024
Enfusion Q2 2024 Earnings Report
Enfusion demonstrated solid performance with revenue growth and margin expansion.
Key Takeaways
Enfusion reported a revenue of $49.5 million, representing a 16% year-over-year growth. The company won 39 new accounts and saw expansion of adjusted EBITDA margin.
The launch market in the Americas showed strength in Q2 2024, with 64% of wins being launches.
Enfusion is gaining deeper penetration across international geographies, expanding in EMEA and APAC regions.
New features were released for Portfolio Workbench, enhancing decision making and customization.
The company is winning more profitable new business with higher annual contract values and longer duration.
Revenue by Segment
Forward Guidance
Enfusion anticipates GAAP revenues between $200-210 million, adjusted EBITDA between $40-45 million, and FCF conversion between 50-55%.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...